MITF and melanoma: Furthermore, enrichment of microRNA (miR)-100-5p and miR-125b-5p was detected in the “MITF-low” cluster of melanoma samples in TCGA, and among the evaluated tumor patients, the expression of these miRs was higher in the immunotherapy responders than in the nonresponders15,18.